COFCO Biotechnology (000930) Stock Overview
Engages in the processing and production of biochemical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
000930 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
COFCO Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.54 |
| 52 Week High | CN¥7.03 |
| 52 Week Low | CN¥5.26 |
| Beta | 0.58 |
| 1 Month Change | 9.36% |
| 3 Month Change | 6.17% |
| 1 Year Change | 21.34% |
| 3 Year Change | -25.09% |
| 5 Year Change | -27.33% |
| Change since IPO | -58.01% |
Recent News & Updates
Recent updates
COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Prospects Need A Boost To Lift Shares
Feb 24
COFCO Biotechnology (SZSE:000930) Is Making Moderate Use Of Debt
Jan 07COFCO Biotechnology Co., Ltd. (SZSE:000930) Surges 39% Yet Its Low P/S Is No Reason For Excitement
Oct 14We Think COFCO Biotechnology (SZSE:000930) Has A Fair Chunk Of Debt
Sep 30COFCO Biotechnology Co., Ltd. (SZSE:000930) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 17COFCO Biotechnology (SZSE:000930) Is Carrying A Fair Bit Of Debt
Jun 03Returns On Capital Signal Tricky Times Ahead For COFCO Biotechnology (SZSE:000930)
Apr 17COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Price Is Right But Growth Is Lacking
Mar 07Shareholder Returns
| 000930 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 1.6% | 1.3% | 1.0% |
| 1Y | 21.3% | 52.1% | 30.7% |
Return vs Industry: 000930 underperformed the CN Chemicals industry which returned 52.1% over the past year.
Return vs Market: 000930 underperformed the CN Market which returned 30.7% over the past year.
Price Volatility
| 000930 volatility | |
|---|---|
| 000930 Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 9.7% |
| 10% least volatile stocks in CN Market | 3.1% |
Stable Share Price: 000930 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000930's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 5,261 | De Guo Zhang | www.cofcotech.com |
COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing and production of biochemical products in China. The company offers edible corn, special, waxy corn, and modified waxy corn starch; feed products, such as corn gluten meal, sprayed corn husk, corn germ meal, DDGS, fertilizer raw materials and glutamic acid residue; sweeteners comprising special syrup for frozen dough, compound fructose powder, maltodextrin, and fructose and glucose syrups; edible alcohol and fuel ethanol; and monosodium glutamate, anhydrous citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd.
COFCO Biotechnology Co., Ltd. Fundamentals Summary
| 000930 fundamental statistics | |
|---|---|
| Market cap | CN¥11.94b |
| Earnings (TTM) | CN¥94.71m |
| Revenue (TTM) | CN¥18.19b |
Is 000930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000930 income statement (TTM) | |
|---|---|
| Revenue | CN¥18.19b |
| Cost of Revenue | CN¥17.06b |
| Gross Profit | CN¥1.13b |
| Other Expenses | CN¥1.04b |
| Earnings | CN¥94.71m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 24, 2026
| Earnings per share (EPS) | 0.051 |
| Gross Margin | 6.24% |
| Net Profit Margin | 0.52% |
| Debt/Equity Ratio | 36.0% |
How did 000930 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/11 15:18 |
| End of Day Share Price | 2026/02/11 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
COFCO Biotechnology Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Liu | Haitong International Research Limited |
| Jiao Chen | Industrial Securities Co. Ltd. |
| Li Wu | Tianfeng Securities Brokerage Co., Ltd |